North America Neurological Biomarkers Market Developments and Forecast by 2027

North America Neurological Biomarkers Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Others); Application (Alzheimer's Disease, Parkinson's Disease, Schizophrenia, Huntington's Disease, Spinal Muscular Atrophy, Others); End User (Pharmaceutical and Biotechnology Companies, Clinical Diagnostics, Research Organizations), and Country

Report Date : Aug 2020
Report Code : TIPRE00013306

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 139

The North America neurological biomarkers market is expected to reach US$ 2,618.68 Mn in 2027 from US$ 7,056.76 Mn in 2019. The market is estimated to grow with a CAGR of 13.4% from 2020-2027.

Factors such as growing prevalence of neurological disorders and increasing focus toward research in neurological biomarker are expected to fuel the growth of the market. However, the limitation of neurological biomarkers is a major factor hindering the market growth.

Biomarkers are the molecules that indicate about the presence of a disease. The biomarkers of the neurological diseases were not that accessible in earlier days, however the advancements in the technology have enabled to track the health condition of the brain by measuring the biomarkers. This helps in the earlier detection of a disease, less invasive diagnostics and enables faster drug development and is expected to be the effective treatment.

Neurological diseases contribute to a significant burden on health systems in terms of disease diagnosis, treatment, and management. Some of the major neurological disorders are epilepsy, Alzheimer’s disease, multiple sclerosis, spinal muscular atrophy (SMA), Duchenne muscular dystrophy, and others. As per the data published by the National Institutes of Neurological Disorders and Stroke in 2019, around 7,000 rare neurological diseases have been registered in the US. Additionally, according to the same study, these conditions are responsible for a significant number of morbidity and mortality. As per the 2019 Alzheimer’s disease Facts and Figures Report, in the year 2019, there were 5.8 million Americans of all ages were suffering from Alzheimer’s dementia. Among 5.8 million patients, 81% of the patients were aged 75 years and above. According to the Global Burden Disease (GBD) 2017, and Disease and Injury Incidence and Prevalence report, 20 million people across the globe suffer from Schizophrenia. Additionally, as per the Bio News Services, LLC, seven to ten million people across the globe suffer from Parkinson’s disease.Thus, increasing prevalence of neurological diseases is a major factor driving the growth of the North America neurological biomarker market during the forecast period.

Research institutes, pharmaceutical, and biotech companies are engaged in collaborative work to address the COVID-19 outbreak. This has eventually shifted their focus from development of new neurological biomarkers to vaccine development for COVID-19. Moreover, diversion of resources from neurological biomarkers development to COVID-19 treatment is likely to hamper overall productivity of the drug development during the forecast period. Furthermore, pharmaceutical supplies and procurement are also badly affected by the outbreak of COVID-19 in North America.

Mexico Neurological Biomarkers Market Revenue and Forecasts to 2027 (US$ Millio

n)

Inquire for Discount

Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Request discounts available for Start-Ups & Universities

NORTH AMERICANEUROLOGICAL BIOMARKERS MARKET SEGMENTATION

By Product

Proteomics Biomarker
Genomics Biomarker
Metabolomics Biomarker
Imaging Biomarker
Others

By Application

Alzheimer’s Disease
Parkinson's Disease
Schizophrenia
Huntington's Disease
Spinal Muscular Atrophy
Others

By End User

Pharmaceutical and Biotechnology Companies
Clinical Diagnostics
Research Organizations

By Country

US
Canada
Mexico

Companies Mentioned

Thermo Fisher Scientific, Inc
Bio-Rad Laboratories Inc.
Banyan Biomarkers
Abbott
Quest Diagnostics Incorporated
Perkin Elmer, Inc.

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

Product, Application, End User, and Country

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

US, Canada

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Neurological Biomarkers Market – By Product

1.3.2 North America Neurological Biomarkers Market – By Application

1.3.3 North America Neurological Biomarkers Market – By End User

1.3.4 North America Neurological Biomarkers Market – By Country

2. North America Neurological Biomarkers Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Neurological Biomarkers Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Neurological Biomarkers Market - North America PEST Analysis

4.3 Expert Opinion

5. North America Neurological Biomarkers Market - Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Growing Prevalence of Neurological Disorders

5.1.2 Increasing Focus Toward Research in Neurological Biomarkers

5.2 Key Market Restraints

5.2.1 Limitations of Neurological Biomarkers

5.3 Market Opportunities

5.3.1 Increasing Awareness Toward Benefits of Early Diagnosis

5.4 Future Trends

5.4.1 Trend Shift Towards Personalized/Precision Medicine

5.5 Impact analysis

6. Neurological Biomarkers Market – North America Analysis

6.1 North America Neurological Biomarkers Market Revenue Forecasts and Analysis

7. North America Neurological Biomarkers Market Analysis And Forecasts To 2027 – By Product

7.1 Overview

7.2 North America Neurological Biomarkers market, By Product 2019 & 2027 (%)

7.2.1 North America Neurological Biomarkers Market Revenue and Forecasts to 2027, By Product (US$ Mn)

7.3 Proteomics Biomarker

7.3.1 Overview

7.3.2 North America Proteomics Biomarker Market Revenue and Forecast to 2027 (US$ Mn)

7.4 Genomics Biomarker

7.4.1 Overview

7.4.2 North America Genomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.5 Metabolomics Biomarker

7.5.1 Overview

7.5.2 North America Metabolomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.6 Imaging Biomarker

7.6.1 Overview

7.6.2 North America Imaging Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.7 Others

7.7.1 Overview

7.7.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

8. North America Neurological Biomarkers Market Analysis – By Application

8.1 Overview

8.2 North America Neurological Biomarkers Market, By Application 2019-2027 (%)

8.2.1 North America Neurological Biomarkers Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3 Alzheimer’s Disease

8.3.1 Overview

8.3.2 North America Alzheimer’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.4 Parkinson’s Disease

8.4.1 Overview

8.4.2 North America Parkinson’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.5 Schizophrenia

8.5.1 Overview

8.5.2 North America Schizophrenia Market Revenue and Forecasts to 2027 (US$ Mn)

8.6 Huntington's Disease

8.6.1 Overview

8.6.2 North America Huntington's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.7 Spinal Muscular Atrophy

8.7.1 Overview

8.7.2 North America Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)

8.8 Others

8.8.1 Overview

8.8.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

9. North America Neurological Biomarkers Market Analysis – By End User

9.1 Overview

9.2 North America Neurological Biomarkers Market, By End User 2019-2027 (%)

9.2.1 North America Neurological Biomarkers Market Revenue and Forecasts to 2027, By End User (US$ Mn)

9.3 Pharmaceutical and Biotechnology Companies

9.3.1 Overview

9.3.2 North America Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)

9.4 Clinical Diagnostics

9.4.1 Overview

9.4.2 North America Clinical Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

9.5 Research Organizations

9.5.1 Overview

9.5.2 North America Research Organizations Market Revenue and Forecasts to 2027 (US$ Mn)

10. Neurological Biomarkers Market Revenue and Forecasts To 2027 – Geographical Analysis

10.1 North America: Neurological Biomarker Market

10.1.1 Overview

10.1.2 North America: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.3 North America: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.4 North America: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.5 North America: Neurological Biomarker Market, by End-User, 2018–2027 (USD Million)

10.1.6 North America: Neurological Biomarker Market, by Country, 2019& 2027 (%)

10.1.7 US: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1 US: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2 US: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.7.3 US: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.7.4 US: Neurological Biomarker Market, by End-User, 2018–2027 (USD Million)

10.1.8 Canada: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1 Canada: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2 Canada: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.8.3 Canada: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.8.4 Canada: Neurological Biomarker Market, by End-User, 2018–2027 (USD Million)

10.1.9 Mexico: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1 Mexico: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2 Mexico: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.9.3 Mexico: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.9.4 Mexico: Neurological Biomarker Market, by End-User, 2018–2027 (USD Million)

11. Impact of COVID-19 Pandemic on North America Neurological Biomarkers Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

12. Company Profiles

12.1 Thermo Fisher Scientific Inc.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Abbott

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Bio-Rad Laboratories Inc.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Banyan Biomarkers, Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Quest Diagnostics Incorporated

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Perkin Elmer, Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

13. Appendix

13.1 About the Insight Partners

13.2 Word Index

LIST OF TABLES

Table 1. North America Neurological Biomarkers Market Revenue and Forecasts To 2027, By Product (US$ Mn)

Table 2. North America Neurological Biomarkers Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 3. North America Neurological Biomarkers Market Revenue and Forecasts To 2027, By End User (US$ Mn)

Table 4. North America Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 5. North America Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 6. North America Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 7. US Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 8. US Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9. US Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 10. Canada Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 11. Canada Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 12. Canada Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 13. Mexico Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 14. Mexico Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15. Mexico Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 16. List of Abbreviation

LIST OF FIGURES

Figure 1. Neurological Biomarkers Market Segmentation

Figure 2. North America Neurological Biomarkers Market Overview

Figure 3. Genomic Biomarkers Segment Held Largest Share of Neurological Biomarker Market

Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. North America Neurological Biomarkers Market - Leading Country Markets (US$ Mn)

Figure 6. Neurological Biomarkers Market - North America PEST Analysis

Figure 7. Neurological Biomarkers Market Impact Analysis Of Driver And Restraints

Figure 8. North America Neurological Biomarkers market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9. North America Neurological Biomarkers market, By Product 2019 & 2027 (%)

Figure 10. North America Proteomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11. North America Genomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12. North America Metabolomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13. North America Imaging Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15. North America Neurological Biomarkers Market, by Application 2019 & 2027 (%)

Figure 16. North America Alzheimer’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17. North America Parkinson’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18. North America Schizophrenia Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19. North America Huntington's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20. North America Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22. North America Neurological Biomarkers Market, by End User 2019 & 2027 (%)

Figure 23. North America Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24. North America Clinical Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25. North America Research Organizations Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26. North America: Neurological Biomarker Market, by Key Country – Revenue (2019) (USD Million)

Figure 27. North America Neurological Biomarker Market Revenue and Forecast to 2027 (USD Million)

Figure 28. North America: Neurological Biomarker Market, by Country, 2019 & 2027 (%)

Figure 29. US: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 30. Canada: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 31. Mexico: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 32. Impact of COVID-19 Pandemic in North American Country Markets

Thermo Fisher Scientific, Inc
Bio-Rad Laboratories Inc.
Banyan Biomarkers
Abbott
Quest Diagnostics Incorporated
Perkin Elmer, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
Validates and strengthens in-house secondary research findings
Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

Industry participants: VPs, business development managers, market intelligence managers and national sales managers
Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.